Prophylactic modified donor lymphocyte infusion after low-dose ATG-F-based haploidentical HSCT with myeloablative conditioning in high-risk acute leukemia: a matched-pair analysis

Outcomes and Prognostic Factors for Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia Who Underwent Allogeneic Hematopoietic Cell Transplantation: A KSGCT Multicenter Analysis

(2020) Takayoshi Tachibana et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Clinical applications of donor lymphocyte infusion from an HLA-haploidentical donor: consensus recommendations from the acute leukemia working party of the EBMT

(2019) Bhagirathbhai Dholaria et al.   HAEMATOLOGICA

Minimal/measurable residual disease in AML: a consensus document from the European LeukemiaNet MRD Working Party

(2018) Gerrit J. Schuurhuis et al.   BLOOD

Relapse and survival after transplantation for complex karyotype acute myeloid leukemia: A report from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation and the University of Texas MD Anderson Cancer Center

(2018) Stefan O. Ciurea et al.   CANCER

Donor lymphocyte infusion for prevention of relapse after unmanipulated haploidentical PBSCT for very high-risk hematologic malignancies

(2018) Xiao-Ning Gao et al.   ANNALS OF HEMATOLOGY

Prophylactic donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation for high risk haematological malignancies: a retrospective bicentric analysis of serial infusions of increasing doses of CD3+ cells

(2018) Raphael Cauchois et al.   BRITISH JOURNAL OF HAEMATOLOGY

The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China

(2018) Yu Wang et al.   CANCER LETTERS

Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia - a matched pair analysis by the Acute Leukaemia Working Party of EBMT

(2018) Christoph Schmid et al.   BRITISH JOURNAL OF HAEMATOLOGY

Haploidentical versus unrelated allogeneic stem cell transplantation for relapsed/refractory acute myeloid leukemia: A report of 1578 patients from the Acute Leukemia Working Party of EBMT

(2018) Eolia Brissot et al.   HAEMATOLOGICA

Improved Outcome of Refractory/Relapsed Acute Myeloid Leukemia after Post-Transplantation Cyclophosphamide-Based Haploidentical Transplantation with Myeloablative Conditioning and Early Prophylactic Granulocyte Colony-Stimulating Factor–Mobilized Donor Lymphocyte Infusions

(2016) Sarita Rani Jaiswal et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation for high-risk AML

(2016) F Legrand et al.   BONE MARROW TRANSPLANTATION

TP53mutation in patients with high-risk acute myeloid leukaemia treated with allogeneic haematopoietic stem cell transplantation

(2016) Jan M. Middeke et al.   BRITISH JOURNAL OF HAEMATOLOGY

Pre- and post-transplant quantification of measurable (‘minimal’) residual disease via multiparameter flow cytometry in adult acute myeloid leukemia

(2016) Y Zhou et al.   LEUKEMIA

Composite end point of graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic cell transplantation

(2015) S. G. Holtan et al.   BLOOD

Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation

(2015) Z Jedlickova et al.   BONE MARROW TRANSPLANTATION

Donor Lymphocyte Infusion for the Treatment of Relapsed Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation: A Retrospective Analysis by the Adult Acute Myeloid Leukemia Working Group of the Japan Society for Hematopoietic Cell Transplantation

(2014) Akiyoshi Takami et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

T-cell-replete haploidentical HSCT with low-dose anti-T-lymphocyte globulin compared with matched sibling HSCT and unrelated HSCT

(2014) Y. Luo et al.   BLOOD

Donor Lymphocyte Infusion for Relapsed Hematological Malignancies after Allogeneic Hematopoietic Cell Transplantation: Prognostic Relevance of the Initial CD3+ T Cell Dose

(2013) Merav Bar et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

HLA-Haploidentical Donor Lymphocyte Infusions for Patients with Relapsed Hematologic Malignancies after Related HLA-Haploidentical Bone Marrow Transplantation

(2013) Amer M. Zeidan et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Myeloablative T cell-depleted alloSCT with early sequential prophylactic donor lymphocyte infusion is an efficient and safe post-remission treatment for adult ALL

(2013) M Eefting et al.   BONE MARROW TRANSPLANTATION

Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation

(2013) T Schroeder et al.   LEUKEMIA

High Alloreactivity of Low-Dose Prophylactic Donor Lymphocyte Infusion in Patients with Acute Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation with an Alemtuzumab-Containing Conditioning Regimen

(2012) Maria Liga et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Prevention of relapse using DLI can increase survival following HLA-identical transplantation in patients with advanced-stage acute leukemia: a multi-center study

(2012) Yu Wang et al.   CLINICAL TRANSPLANTATION

Prevention of relapse using granulocyte CSF-primed PBPCs following HLA-mismatched/haploidentical, T-cell-replete hematopoietic SCT in patients with advanced-stage acute leukemia: a retrospective risk-factor analysis

(2011) Y Wang et al.   BONE MARROW TRANSPLANTATION

Analysis of Risk Factors for Outcomes After Unrelated Cord Blood Transplantation in Adults With Lymphoid Malignancies: A Study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

(2008) Celso A. Rodrigues et al.   JOURNAL OF CLINICAL ONCOLOGY